Multiple Sclerosis (MS) Drugs Report

By www.reliableresearchtimes.com

Report Details

Report Name

Global And United States Multiple Sclerosis (MS) Drugs Market Report & Forecast 2024-2031 Story

Pages

115

Price

$ 4350

Features

Multiple Sclerosis (MS) Drugs Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Bayer AG
Bayhill Therapeutics
Biogen Idec
Cinnagen
Daiichi Sankyo
Eli Lilly
Fast Forward Llc
Antisense Therapeutics
Apitope
Five Prime Therapeutics
Genmab
Artielle Immunotherapeutics
Genzyme
Glaxosmithkline
Gw Pharmaceuticals
Innate Immunotherapeutics